WAM
RXII

Wolverine Asset Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Wolverine Asset Management’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-20,900
Closed -$30K – 2209
2015
Q4 		$30K Sell
20,900
-9,000
-30% -$12.9K ﹤0.01% 1246
2015
Q3 		$47K Hold
29,900
– – ﹤0.01% 1286
2015
Q2 		$50K Buy
+29,900
New +$50K ﹤0.01% 1307
2015
Q1 		– Sell
-138,200
Closed -$208K – 2811
2014
Q4 		$208K Buy
138,200
+30,700
+29% +$46.2K ﹤0.01% 945
2014
Q3 		$221K Buy
107,500
+27,100
+34% +$55.7K 0.01% 1014
2014
Q2 		$246K Buy
+80,400
New +$246K 0.01% 846

Other funds holding RXII

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return